PUBLICATIONS 2012

Original papers:

Jacques C, Holzenberger M, Mladenovic Z, Salvat C, Pecchi E, Berenbaum F, Gosset M. Pro-inflammatory actions of visfatin/Nampt involve regulation of insulin signaling pathway and Nampt enzymatic activity. J Biol Chem. 2012 Apr 27;287(18):15100-8.

Hodkinson B, Maheu E, Michon M, Carrat F, Berenbaum F. Assessment and determinants of aesthetic discomfort in hand osteoarthritis. Ann Rheum Dis. 2012 Jan;71(1):45-9. Epub 2011 Sep 6.

Pecchi E, Priam S, Mladenovic Z, Gosset M, Saurel AS, Aguilar L, Berenbaum F, Jacques C.  A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E2 and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts.Osteoarthritis Cartilage. 2012 Feb;20(2):127-35. Epub 2011 Dec 11.

Chauffier K, Laiguillon MC, Bougault C, Gosset M, Priam S, Salvat C, Mladenovic Z, Nourissat G, Jacques C, Houard X, Berenbaum F, Sellam J. Induction of the chemokine IL-8/Kc by the articular cartilage: Possible influence on osteoarthritis.Joint Bone Spine. 2012 Feb 15. [Epub ahead of print]

Berenbaum F, Grifka J, Cazzaniga S, D'Amato M, Giacovelli G, Chevalier X, Rannou F, Rovati LC, Maheu E.A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis.Ann Rheum Dis. 2012 Jan 31.

Fautrel B, Combe B, Rincheval N, Dougados M; ESPOIR Scientific Committee.Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data.Ann Rheum Dis. 2012 Mar;71(3):386-9. Epub 2011 Oct 28.

Chauffier K, Salliot C, Berenbaum F, Sellam J.Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis.Rheumatology (Oxford). 2012 Jan;51(1):60-8. Epub 2011 Apr 22.

Pham T, Berthelot JM, Blacher J, Constantin A, Gaudin P, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Lequerré T, Marolleau JP, Martinez V, Masson C, Mouthon L, Puéchal X, Richette P, Saraux A, Schaeverbeke T, Sellam J, Soubrier M, VittecoqO, Wendling D, Mariette X, Sibilia J. Prise en charge pratique des patients sous rituximab. Fiches pratiques élaborées par le Club Rhumatismes et Inflammation (CRI), mise à jour 2012. Rev Rhum, 2012,

Kemta Lekpa F, Poulain C, Wendling D, Soubrier M, De Bandt M, Berthelot JM, Gaudin P, Toussirot E, Goupille P, Pham T, Sellam J, Bruckert R, Paul M, Farrenq V, Claudepierre P, on behalf of the Club Rhumatismes et Inflammations.Is interleukin-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multi-center retrospective observational study. Arthritis Res Ther 2012, 9;14(2):R53

Puéchal X, Gottenberg JE, Berthelot JM, Gossec L, Meyer O, Morel J, Wendling D, de Bandt M, Houvenagel E, Jamard B, Lequerr T, Morel G, Richette P, Sellam J, Guillevin L, Mariette X; on Behalf of the Investigators of the AutoImmunity and Rituximab registry. Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis. Results from the autoimmunity and rituximab registry. Arthritis Care Res (Hoboken) 2012 64(3):331-9

 

Reviews:

Berenbaum F.Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype.Postgrad Med J. 2012 Apr;88(1038):240-2.

Majhoub M, Berenbaum F, Houard X. Why subchondral bone in osteoarthritis ? The importance of the cartilage bone interface in osteoarthritis.O steoporosis Int. Sous presse.

Sellam J, Berenbaum F. Osteoarthritis and obesity.Rev Praticien 2012 May;62(5):621-4

Sellam J, Berenbaum F. When to refer a patient with osteoarthritis to the surgeon ?.Rev Praticien 2012 May;62(5):644-647